Drug Therapy for Heart Valve Diseases-Reference-Cited by-同舟云学术

Drug Therapy for Heart Valve Diseases

Published:2015-09-15 Issue:11 Volume:132 Page:1038-1045
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Borer Jeffrey S.¹,Sharma Abhishek¹

Affiliation:

1. From Division of Cardiovascular Medicine, The Howard Gilman Institute for Heart Valve Diseases and the Schiavone Institute for Cardiovascular Translational Research, SUNY Downstate Medical Center, Brooklyn and New York, NY.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.115.016006

Reference99 articles.

1. The Epidemiology of Valvular Heart Disease: a Growing Public Health Problem

2. Aortic stenosis

3. Medical treatment ofaortic stenosis

4. Clinical Factors Associated With Calcific Aortic Valve Disease fn1fn1This study was supported in part by Contracts NO1-HC85079 through HC-850086 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

5. HMG CoA reductase inhibitor (statin) and aortic valve calcium

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adult Disease and Syndromes;Anesthesia for Dental and Oral Maxillofacial Surgery;2024-04-12

2. Konservative Therapie von Herzklappenvitien im Erwachsenenalter;Die Innere Medizin;2024-03-04

3. Feeder-free generation and characterization of endocardial and cardiac valve cells from human pluripotent stem cells;iScience;2024-01

4. Drug Delivery Systems and Cardiovascular Disease;Application of Biomaterials in the Treatment of Cardiovascular Diseases;2024

5. Unique Aspects of Women's Valvular Heart Diseases: Impact for Diagnosis and Treatment;CJC Open;2023-11